Good afternoon MSO friends,

I am looking into conducting a gap assessment for our USP797 and 800 practices before next month enforcement date. Does anyone have a gap assessment they can share for USP 797/800.

Any insight is greatly appreciated.

Sincerely,
Mohamed

Good afternoon MSO friends,

I am looking into conducting a gap assessment for our USP797 and 800 practices before next month enforcement date. Does anyone have a gap assessment they can share for USP 797/800.

Any insight is greatly appreciated.

Sincerely,
Mohamed

Our current process for Doe patients is to have the default age of 1/1/1900. Interested to hear if any pediatric institutions have a process to ensure neonatal/pediatric context applies to their patients. We recently had a NICU patient with an age of 123 years old, and it caused a lot of confusion/problems with entering orders correctly.

The most recent ISMP Acute Care newsletter recommended having an escalation process for when a medication barcode will not scan. After surveying some of our pharmacists and nurses it seems that this is a gap our health system has. Do other places already have something like this in place and could share the steps and if it has been successful and utilized? Thanks!

Has anyone implemented Datix RL6 event reporting system? If so, did you make modifications to any of the medication/fluid event section or the supported medication list? Did you use your formulary as the CSV file for medications? I have been asked to review these sections and honestly have no clue how to go make recommendations. Hoping someone has been through this and can help! Thank you.

Carol

Good morning,
Does anyone have a protocol for these indications? This is being done in our health centre (IWK Health, Halifax Nova Scotia). We are a centre which serves pediatric and Women's health population.
In this case it appears that our pediatric ORs and Emergency departments are using.
Any input would be much appreciated.
Best Regards,
Carol

Colleagues responsible for USP Implementation,

My board of pharmacy is not weighing in on the interpretation of sterile compounding direct oversight versus in process and final checks. With the training requirements differing for compounders, those who provide direct oversight, and those who provide in process checks, I am seeking opinions on specifically the distinction between direct oversight and in-process/final checks.

I'm looking for some guidance on how other facilities handle REMS medications from an inpatient perspective. This question was sparked by a recent ISMP newsletter (https://www.ismp.org/resources/incorporating-rems-program-requirements-s...).

For example, suboxone, do you distribute a medication guide to patients on the floor? What is your workflow? REMS guidelines seem to be written for outpatient use, however, I do not see inpatient facility exceptions.

Hello,
Do you have pentobarbital on your high alert list?
We currently do not, but are considering adding it.
Thanks,
Stacie Ethington MSN, RN
Nebraska Medicine

Please fill out this 3 question, <3 minute survey !
I will share results with this group.

It is about the details of Patient own medication use !
thank you in advance !

https://www.surveymonkey.com/r/8XKGV2M